Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer

Cancers Pub Date : 2024-05-14 DOI:10.3390/cancers16101871
M. Sayan, Y. Tuaç, Samet Kucukcolak, Mary D Rowan, Grace K. Pratt, Ç. Aktan, Elza Tjio, Dilara Akbulut, Shalini Moningi, J. E. Leeman, P. Orio, Paul L. Nguyen, Anthony V D'Amico, Mahmut Akgul
{"title":"Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer","authors":"M. Sayan, Y. Tuaç, Samet Kucukcolak, Mary D Rowan, Grace K. Pratt, Ç. Aktan, Elza Tjio, Dilara Akbulut, Shalini Moningi, J. E. Leeman, P. Orio, Paul L. Nguyen, Anthony V D'Amico, Mahmut Akgul","doi":"10.3390/cancers16101871","DOIUrl":null,"url":null,"abstract":"Purpose: Given the variable clinical course of prostate cancer and the limitations of current prognostic factors, this study was conducted to investigate the impact of a histologically overt stromal response (HOST-response) to prostate cancer on clinical outcomes after radical prostatectomy. Methods: This retrospective analysis utilized The Cancer Genome Atlas (TCGA) to evaluate data from individuals with a confirmed diagnosis of prostate cancer who underwent radical prostatectomy and had available pathology slides. These slides were assessed for the presence of a HOST-response, similar to desmoplasia. The primary endpoint was progression-free survival (PFS). A multivariable competing risk regression analysis was used to assess whether a significant association existed between HOST-response and PFS, adjusting for known prostate cancer prognostic factors. Results: Among the 348 patients analyzed, 166 (47.70%) demonstrated a HOST-response. After a median follow-up of 37.87 months (IQR: 21.20, 65.50), the presence of a HOST-response was significantly associated with a shorter PFS (SDHR, 2.10; 95% CI, 1.26 to 3.50; p = 0.004), after adjusting for covariates. Conclusions: HOST-response in prostate cancer patients treated with radical prostatectomy is significantly associated with reduced PFS, suggesting a potential benefit from adjuvant therapy and highlighting the need for further investigation in a prospective randomized clinical trial.","PeriodicalId":504676,"journal":{"name":"Cancers","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/cancers16101871","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Given the variable clinical course of prostate cancer and the limitations of current prognostic factors, this study was conducted to investigate the impact of a histologically overt stromal response (HOST-response) to prostate cancer on clinical outcomes after radical prostatectomy. Methods: This retrospective analysis utilized The Cancer Genome Atlas (TCGA) to evaluate data from individuals with a confirmed diagnosis of prostate cancer who underwent radical prostatectomy and had available pathology slides. These slides were assessed for the presence of a HOST-response, similar to desmoplasia. The primary endpoint was progression-free survival (PFS). A multivariable competing risk regression analysis was used to assess whether a significant association existed between HOST-response and PFS, adjusting for known prostate cancer prognostic factors. Results: Among the 348 patients analyzed, 166 (47.70%) demonstrated a HOST-response. After a median follow-up of 37.87 months (IQR: 21.20, 65.50), the presence of a HOST-response was significantly associated with a shorter PFS (SDHR, 2.10; 95% CI, 1.26 to 3.50; p = 0.004), after adjusting for covariates. Conclusions: HOST-response in prostate cancer patients treated with radical prostatectomy is significantly associated with reduced PFS, suggesting a potential benefit from adjuvant therapy and highlighting the need for further investigation in a prospective randomized clinical trial.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
前列腺癌根治性前列腺切除术后组织学上明显的间质反应和病情恶化的风险
目的:鉴于前列腺癌的临床病程多变以及目前预后因素的局限性,本研究旨在探讨前列腺癌组织学上明显的基质反应(HOST-反应)对根治性前列腺切除术后临床预后的影响。研究方法这项回顾性分析利用癌症基因组图谱(The Cancer Genome Atlas,TCGA)对确诊为前列腺癌、接受前列腺癌根治术并有病理切片的患者的数据进行评估。对这些病理切片进行了评估,以确定是否存在与脱落细胞类似的 HOST 反应。主要终点是无进展生存期(PFS)。在对已知的前列腺癌预后因素进行调整后,采用多变量竞争风险回归分析来评估HOST反应与无进展生存期之间是否存在显著关联。结果在分析的 348 例患者中,有 166 例(47.70%)表现出 HOST 反应。中位随访时间为 37.87 个月(IQR:21.20 至 65.50),在调整了协变量后,HOST 反应与较短的 PFS 显著相关(SDHR,2.10;95% CI,1.26 至 3.50;p = 0.004)。结论接受根治性前列腺切除术治疗的前列腺癌患者的HOST反应与PFS的缩短有显著相关性,这表明辅助治疗可能会带来益处,并强调有必要在前瞻性随机临床试验中进行进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints Development and Characterization of Syngeneic Orthotopic Transplant Models of Obesity-Responsive Triple-Negative Breast Cancer in C57BL/6J Mice The Effects of Gynecological Tumor Irradiation on the Immune System A Monocentric Analysis of Implantable Ports in Cancer Treatment: Five-Year Efficacy and Safety Evaluation Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1